The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

Jun. 03, 2021
Applicants:

Xenotherapeutics, Inc., Boston, MA (US);

Alexis Bio, Inc., Grantham, NH (US);

Inventors:

Paul Holzer, Enfield, NH (US);

Rodney L. Monroy, North Fort Myers, FL (US);

Andrey Ptitsyn, Revere, MA (US);

Elizabeth Chang, Pittsford, NY (US);

Jon Adkins, Londonderry, NH (US);

Travis Brown, Columbia, MO (US);

Kaitlyn Rogers, Madisonville, LA (US);

Assignees:

XENOTHERAPEUTICS, INC., Boston, MA (US);

ALEXIS BIO, INC., Grantham, NH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06G 7/48 (2006.01); G16B 35/20 (2019.01); G16B 5/20 (2019.01); G16B 40/00 (2019.01); C12N 15/10 (2006.01); G16H 50/20 (2018.01); G16H 70/60 (2018.01); G16H 10/60 (2018.01); G16H 10/40 (2018.01); G06N 20/00 (2019.01); G16H 50/70 (2018.01); G16H 20/10 (2018.01);
U.S. Cl.
CPC ...
G16B 35/20 (2019.02); C12N 15/1089 (2013.01); G06N 20/00 (2019.01); G16B 5/20 (2019.02); G16B 40/00 (2019.02); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 50/20 (2018.01); G16H 50/70 (2018.01); G16H 70/60 (2018.01); G16H 20/10 (2018.01);
Abstract

A method for predictive engineering of a sample derived from a genetically optimized non-human donor suitable for xenotransplantation into a human having improved quality or performance is provided. The method includes constructing a training data set from a series of libraries, wherein at least one library in the series of libraries comprises genomic, proteomic, and research data specific to non-humans. The method includes developing a predictive machine learning model based on the constructed training data set. The method includes utilizing the predictive machine learning model to obtain a predicted quality or performance of a plurality of sequences for a candidate sample from the non-human donor specific to a human patient or patient population. The method includes selecting a subset of sequences for evaluation from the plurality of sequences based on the predicted quality or performance. The method includes designing candidate samples derived from the non-human donor using the selected subset of sequences. The method includes measuring a respective in silico performance of each designed candidate sample. The method includes selecting a designed candidate sample for manufacture based on the respective in silico performance of each designed candidate sample.


Find Patent Forward Citations

Loading…